Literature DB >> 24426221

Impact of CCL2 and Its Receptor CCR2 Gene Polymorphism in North Indian Population: A Comparative Study in Different Ethnic Groups Worldwide.

Vibha Singh1, Neena Srivastava2, Priyanka Srivastava1, Rama Devi Mittal1.   

Abstract

Chemokine are small, inducible pro-inflammatory cytokines involved in many biological processes, such as migration of leukocytes, atherosclerosis, angiogenesis, tumor growth, and metastasis. Chemokine are also known to influence tumor cell's activity. Specifically, tumor cells express chemokine receptors in a non random manner suggesting a role of chemokine in metastatic destination of tumor cells. The present study was conducted to determine distribution of (Chemokine receptor 2) CCR2 V64I, Chemokine ligand 2 CCL2 I/D, and CCL2 2518 A>G gene polymorphisms in North Indian population and compare with different populations globally. Polymerase chain reaction (PCR)-based analysis was conducted in 200 normal healthy individuals of similar ethnicity. Allelic frequencies in wild type (GG) of CCR2 V64I G>A were 63 % G; CCL2 I/D 42 % II; CCL2 2518 A>G 40.5 % A. The minor variant allele frequency in our population was as follows: 19.5 % for CCR2 V64I, 35.5 % for CCL2 I/D, 35.3 % for CCL2 2518 A>G. We further compared frequency distribution for these genes with various published studies in different ethnicity. Our results suggested that frequency in chemokine genes exhibit distinctive pattern in India that could be attributed to ethnicity variation. This could assist in high-risk screening of human exposed to environmental carcinogens and cancer predisposition in different ethnic groups. Thus, they signify an impact of ethnicity and provide a basis for future epidemiological and clinical studies.

Entities:  

Keywords:  Bladder cancer; Chemokine gene; North India; PCR–RFLP; SNPs

Year:  2012        PMID: 24426221      PMCID: PMC3689333          DOI: 10.1007/s12291-012-0265-0

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  28 in total

Review 1.  Race, ancestry, and genes: implications for defining disease risk.

Authors:  Rick A Kittles; Kenneth M Weiss
Journal:  Annu Rev Genomics Hum Genet       Date:  2003       Impact factor: 8.929

2.  MCP-1 and CCR2 gene variants in oral squamous cell carcinoma.

Authors:  K Bektas-Kayhan; M Unur; Z Boy-Metin; B Cakmakoglu
Journal:  Oral Dis       Date:  2011-08-24       Impact factor: 3.511

Review 3.  Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases.

Authors:  S Ye
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

4.  CCL2 -2518 A/G single nucleotide polymorphism as a risk factor for breast cancer.

Authors:  Lukasz Kruszyna; Margarita Lianeri; Błażej Rubis; Hanna Knuła; Maria Rybczyńska; Sylwia Grodecka-Gazdecka; Paweł P Jagodziński
Journal:  Mol Biol Rep       Date:  2010-06-20       Impact factor: 2.316

5.  Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients.

Authors:  Biying Zheng; Fredrik Wiklund; Baback Gharizadeh; Mehdi Sadat; Giovanni Gambelunghe; Göran Hallmans; Joakim Dillner; Keng-Ling Wallin; Mehran Ghaderi
Journal:  Anticancer Res       Date:  2006 Sep-Oct       Impact factor: 2.480

Review 6.  CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis.

Authors:  Jian Zhang; Lalit Patel; Kenneth J Pienta
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-14       Impact factor: 7.638

Review 7.  Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both?

Authors:  Richard O Hynes
Journal:  Cell       Date:  2003-06-27       Impact factor: 41.582

8.  Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients.

Authors:  Monika Buraczynska; Anna Bednarek-Skublewska; Kinga Buraczynska; Andrzej Ksiazek
Journal:  Cytokine       Date:  2008-11-17       Impact factor: 3.861

Review 9.  The chemokine and chemokine receptor superfamilies and their molecular evolution.

Authors:  Albert Zlotnik; Osamu Yoshie; Hisayuki Nomiyama
Journal:  Genome Biol       Date:  2006       Impact factor: 13.583

10.  Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians.

Authors:  Tarunveer Singh Ahluwalia; Madhu Khullar; Monica Ahuja; Harbir Singh Kohli; Anil Bhansali; Viswanathan Mohan; Radha Venkatesan; Taranjit Singh Rai; Kamal Sud; Pawan K Singal
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

View more
  1 in total

1.  Monocyte chemotactic protein-1 promotes the proliferation and invasion of osteosarcoma cells and upregulates the expression of AKT.

Authors:  Quanchi Chen; Wei Sun; Yuxin Liao; Hui Zeng; Liancheng Shan; Fei Yin; Zhuoying Wang; Zifei Zhou; Yingqi Hua; Zhengdong Cai
Journal:  Mol Med Rep       Date:  2015-02-18       Impact factor: 2.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.